Patwardhan, A. M., Jeske, N. A., Price, T. J., Gamper, N., Akopian, A. N., & Hargreaves, K. M. (2006). The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. National Academy of Sciences.
Chicago-stil citatPatwardhan, Amol M., Nathaniel A. Jeske, Theodore J. Price, Nikita Gamper, Armen N. Akopian, och Kenneth M. Hargreaves. The Cannabinoid WIN 55,212-2 Inhibits Transient Receptor Potential Vanilloid 1 (TRPV1) and Evokes Peripheral Antihyperalgesia Via Calcineurin. National Academy of Sciences, 2006.
MLA-referensPatwardhan, Amol M., et al. The Cannabinoid WIN 55,212-2 Inhibits Transient Receptor Potential Vanilloid 1 (TRPV1) and Evokes Peripheral Antihyperalgesia Via Calcineurin. National Academy of Sciences, 2006.